Scientific Program

  • September 9 (THU)
  • September 10 (FRI)
09:00-09:10 Opening Ceremony
Symposium 1
09:10 - 11:10 Public health response to COVID-19
Chair :
S1-1 Public health response to COVID-19: National perspective
S1-2 Public health response to COVID-19: Regional perspective
S1-3 Public health response to COVID-19: Global perspective
S1-4 Strategies to flatten the curve: current evidence and practical pitfalls
Symposium 2
09:10 - 11:10 Gram-negative bacteria
Chair :
S2-1 Epidemiology and impact of carbapenem-resistant Acinetobacter and Pseudomonas
S2-2 Epidemiology and impact of carbapenem-resistant Enterobacterioceae
S2-3 Emergence of intrinsically resistant gram-negative bacteria: Stenotrophomonas, Burkholderia, and Chryseobacterium
S2-4 Antimicrobial therapy for carbapenem-resistant gram-negative bacteria
Symposium 3
09:10 - 11:10 How I treat difficult-to-treat infections (interactive)
Chair :
S3-1 How I treat persistent S. aureus bacteremia
S3-2 How I treat vascular graft infections
S3-3 How I treat refractory CMV infection
Plenary Lecture 1
11:10 - 11:50
Chair :
P-1 Pandemic preparedness: are we ready for the future?
Plenary Lecture 2
11:50 - 12:30
Chair :
P-2 Vaccines against SARS-CoV-2
Satellite Symposium 1~3
13:30 - 15:00
Plenary Lecture 3
15:10 - 15:50
Chair :
P-3 Overview of the current status of antimicrobial resistance
Symposium 4
15:50 - 17:20 Clinical management of COVID-19
Chair :
S4-1 Therapeutic options for COVID-19
S4-2 Critical care of patients with severe COVID-19
S4-3 Long-term sequelae of COVID-19
Symposium 5
15:50 - 17:20 Diagnostics/clinical microbiology
S5-1 The future is here: rapid diagnosis of antimicrobial resistance
S5-2 Next-generation sequencing for diagnosis of infectious diseases
S5-3 How to combine novel techniques with stewardship: a real-world experience
Symposium 6
15:50 - 17:20 Antimicrobial stewardship
Chair : (Move to Symposium 1)
S6-1 Shorter the better: current evidence for the shorter duration of antibiotic therapy
S6-2 Incentives for antimicrobial stewardship: situation in Asia
S6-3 Antimicrobial stewardship during the COVID-19 pandemic
S6-4 Antimicrobial stewardship during the COVID-19 pandemic
Satellite Symposium 7~9
17:30 - 18:30
Symposium 7
09:00 - 11:00 Pros and cons (interactive)
Chair :
S7-1 Piperacillin-tazobactam for ESBL-producing Enterobacterales
S7-2 Early oral transition for endocarditis
S7-3 Combination regimen for carbapenem-resistant Acinetobacter infections
Symposium 8
09:00 - 11:00 Gram-positive bacteria
Chair :
S8-1 Update on antimicrobial resistance of Staphylococcus
S8-2 Antimicrobial resistance and treatment options for enterococcal infections
S8-3 How to dose vancomycin: time to go Bayesian?
S8-4 Novel, non-antibiotic therapeutic approaches to bacterial infection
Symposium 9
09:00 - 11:00 Infection prevention and control
Chair :
S9-1 Airborne, droplet, or something in between: physics of respiratory secretions
S9-2 Infection control for COVID-19: theory and practice
S9-3 Environmental cleaning & disinfection: current controversies
S9-4 Outbreak control in healthcare settings
Plenary Lecture 4
11:10 - 11:50
Chair :
P-4 TBD
Plenary Lecture 5
11:50 - 12:30
Chair :
P-5 Promoting the development of novel therapeutic agents
Satellite Symposium 4~6
13:30 - 15:00
Plenary Lecture 6
14:40 - 15:20
Chair :
P-6 Designing and conducting clinical trials that change the practice
Symposium 10
15:50 - 17:20 Fungus
Chair :
S10-1 Epidemiology and impact of anti-fungal resistance in Asia
S10-2 Endemic mycoses in the Asia-Pacific region
S10-3 Novel therapeutic options for invasive fungal infections
S10-4
Symposium 11
15:50 - 17:20 Vaccine
Chair :
S11-1 Future role of vaccines on antibacterial resistance
S11-2 Novel technologies for vaccine development
S11-3 Public communication regarding vaccines
Symposium 12
15:50 - 17:20 HIV
Chair :
S12-1 Update on new strategies for antiretroviral therapy
S12-2 Diagnosis and treatment of HIV with complex resistance
S12-3 Disparities in PrEP access in the Asia Pacific